MenopauseArchives
Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study
Menopause 6 min.
Recent cancer facts show that Breast cancer is the leading cause of cancer in women, constituting 23.8% of new cases of cancer and a leading cause of cancer-related mortality [1]. Global statistics show that the prevalence and incidence of breast cancer among young women are increasing at an alarming...
The hypothalamic estrogen receptor α pathway is involved in high-intensity interval training-induced visceral fat loss in premenopausal rats
Menopause 10 min.
Obesity has become a serious threat to human health. For decades, it has been established that central obesity, rather than total body fat, is a significant risk factor for adverse health outcomes. The excessive accumulation of visceral adipose tissue (VAT) constitutes a significant component of metabolic...
The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials
Menopause 4 min.
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, with one-third of global deaths attributed to it [1, 2]. The risk of CVD increases with menopause, as postmenopausal women experience a reduction in cardioprotective effects [3]. Globally, the prevalence of CVD risk rate inclined...
Optimal extension time after initial endocrine therapy for postmenopausal hormone receptor-positive early-stage breast cancer: a systematic review and meta-analysis
Menopause 4 min.
Breast cancer is the most prevalent form of cancer among females, comprising around 25% of all female malignancies and surpassing lung cancer in incidence [1, 2]. About 60%-70% of all breast cancers are hormone receptor-positive (HR-positive) [3], is treated with endocrine therapy (ET) as a key component,...
